References
- Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985: 312(3): 146–51
- Sinclair RA. The breast: tissue changes and cancer risk. Med J Aust 1988: 149(8): 424–6
- Goodwin PJ, Boyd NF. Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. Am J Epidemiol 1988: 127(6): 1097–108
- Bartow SA, Pathak DR, Black WC, et al. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer: a forensic autopsy study. Cancer 1987: 60(11): 2751–60
References
- Cancer Committee of the College of American Pathologists. Is ‘fibrocystic disease’ of die breast precancerous? Arch Pathol Lab Med 1986: 110(Mar): 171–3
References
- Buechler JR, Malloy W. Drug therapy in the elderly: how to achieve optimum results. Postgrad Med 1989: 85(6): 87–99
- Holt PR. Gastrointestinal drugs in the elderly. Am. J Gastroenterol 1986: 81(6): 403–11
- Welage LS, Schentag JJ. Clinical and pharmacological considerations in the use of cimetidine in the elderly. Geriatr Med Today 1983: 2: 33–41
- Saeed ZA, Norton JA, Frank WO, et al. Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome. Gastroenterology 1989: 96(6): 1393–402
- Sabesin SM. Safety issues with H2-receptor antagonists in the treatment of gastrointestinal disease in the elderly. Pract Gastroenterol 1988: 12(S5): 17–21
- Porter JB, Beard K, Walker AM, et al. Intensive hospital monitoring study of intravenous Cimetidine. Arch Intern Med 1986: 146(11): 2237–9
References
- Jones VA, Hunter JO. Irritable bowel syndrome and Crohn's disease. In: Brostoff J, Challacombe SJ, eds. Food allergy and intolerance. Philadelphia: Baillière Tindall/WB Saunders, 1987: 555–6